Robert F. Pagels

Robert F. Pagels

Auto-generated profile, based on publicly available information

Robert F. Pagels

Department of Chemical and Biological Engineering Princeton University Princeton NJ 08544 USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Journal of Controlled Release
Verified
Journal Article
Closed access
RPRobert F. Pagels
Robert F. Pagels
RPRobert K. Prud'homme
Robert K. Prud'homme

10 January 2018 in Nano Letters
Verified
Journal Article
Closed access
RPRobert F. Pagels
Robert F. Pagels
JEJasmine Edelstein
Jasmine Edelstein
CTChristina Tang
Christina Tang
RPRobert K. Prud'homme
Robert K. Prud'homme

30 April 2015 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
NPNathalie M. Pinkerton
Nathalie M. Pinkerton
MGMarian E. Gindy
Marian E. Gindy
VCVictoria L. Calero‐DdelC
Victoria L. Calero‐DdelC
TWTheodore Wolfson
Theodore Wolfson
RPRobert F. Pagels
Robert F. Pagels
RPRobert K. Prud'homme
Robert K. Prud'homme

7 January 2019 in Journal of Visualized Experiments
Verified
Journal Article
Open access
PDF file
CMChester E. Markwalter
Chester E. Markwalter
RPRobert F. Pagels
Robert F. Pagels
BWBrian K. Wilson
Brian K. Wilson
Kurt RistrophKurt Ristroph
Kurt Ristroph
RPRobert K. Prud'homme
Robert K. Prud'homme
The formulation of a therapeutic compound into nanoparticles (NPs) can impart unique properties. For poorly water-soluble drugs, NP formulations can improve bioavailability and modify drug distribution within the body. For hydrophilic drugs like peptides or proteins, encapsulation within NPs can also provide protection from natural clearance mechanisms. There are few techniques for the production of polymeric NPs that are scalable. Flash NanoPrecipitation (FNP) is a process that uses engineered mixing geometries to produce NPs with narrow size distributions and tunable sizes between 30 and 400 nm. This protocol provides instructions on the laboratory-scale production of core-shell polymeric nanoparticles of a target size using FNP. The protocol can be implemented to encapsulate either hydrophilic or hydrophobic compounds with only minor modifications. The technique can be readily employed in the laboratory at milligram scale to screen formulations. Lead hits can directly be scaled up to gram- and kilogram-scale. As a continuous process, scale-up involves longer mixing process run time rather than translation to new process vessels. NPs produced by FNP are highly loaded with therapeutic, feature a dense stabilizing polymer brush, and have a size reproducibility of ± 6%.

3 March 2016 in Journal of Materials Chemistry B
Verified
Journal Article
Open access
PDF file
CTChristina Tang
Christina Tang
JEJasmine Edelstein
Jasmine Edelstein
JMJohn L. Mikitsh
John L. Mikitsh
EXEdward Xiao
Edward Xiao
AHAaron H. Hemphill
Aaron H. Hemphill
RPRobert K. Prud'homme
Robert K. Prud'homme
Non-invasive medical imaging techniques based on radionuclide imaging are powerful platforms to track the fate of radiolabeled materials for diagnostic or drug delivery applications. Polymer-based nanocarriers tagged with non-standard radionuclides with relatively long half-lives (e.g.64Cu: t1/2 = 12.7 h, 76Br: t1/2 = 16.2 h, 89Zr: t1/2 = 3.3 d, 124I: t1/2 = 4.2 d) may greatly expand applications of nanomedicines in molecular imaging and therapy. However, radiolabeling strategies that ensure stable in vivo association of the radiolabel with the nanocarrier remain a significant challenge. In this study, we covalently attach radioiodine to the core of pre-fabricated nanocarriers. First, we encapsulated polyvinyl phenol within a poly(ethylene glycol) coating using Flash NanoPrecipitation (FNP) to produce stable 75 nm and 120 nm nanocarriers. Following FNP, we radiolabeled the encapsulated polyvinyl phenol with 125I via electrophilic aromatic substitution in high radiochemical yields (>90%). Biodistribution studies reveal low radioactivity in the thyroid, indicating minimal leaching of the radiolabel in vivo. Further, PEGylated [125I]PVPh nanocarriers exhibited relatively long circulation half-lives (t1/2α = 2.9 h, t1/2β = 34.9 h) and gradual reticuloendothelial clearance, with 31% of injected dose in blood retained at 24 h post-injection.

12 December 2019 in Macromolecular Chemistry and Physics
Verified
Journal Article
Closed access
PDF file
RPRobert F. Pagels
Robert F. Pagels
NPNathalie M. Pinkerton
Nathalie M. Pinkerton
AYAdam W. York
Adam W. York
RPRobert K. Prud'homme
Robert K. Prud'homme